Source:http://linkedlifedata.com/resource/pubmed/id/10413894
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-10-21
|
pubmed:abstractText |
Natural killer (NK) activity is impaired in patients with positive serology for the human immunodeficiency virus (HIV). We previously found an inhibitory effect of sera from hemophilic (He) HIV+ patients on normal NK activity. In the present study, we have further characterized this effect by studying its reversibility, temperature and time incubation dependence. Since interleukin 2 (IL-2) is able to enhance NK levels, we analyzed the capacity of this lymphokine to reverse the effect of He HIV+ sera. We found that when IL-2 activation of NK activity occurred simultaneously or after HIV+ serum-treatment, a significant restoration of NK function was observed. In contrast, preincubation with IL-2 did not affect the inhibitory effect exerted by HIV+ sera.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0025-7680
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
162-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10413894-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:10413894-Cytotoxicity, Immunologic,
pubmed-meshheading:10413894-HIV Infections,
pubmed-meshheading:10413894-Hemophilia A,
pubmed-meshheading:10413894-Humans,
pubmed-meshheading:10413894-Interleukin-2,
pubmed-meshheading:10413894-Killer Cells, Natural,
pubmed-meshheading:10413894-Time Factors
|
pubmed:year |
1999
|
pubmed:articleTitle |
Interleukin-2 restores natural killer activity inhibited by sera from HIV+ hemophilic patients.
|
pubmed:affiliation |
División de Immunología, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|